Effect of Apolipoprotein E Genotype and Diet on Apolipoprotein E Lipidation and Amyloid Peptides
Author(s) -
Angela J. Hanson,
Jennifer L. Bayer-Carter,
Pattie S. Green,
Thomas J. Montine,
Charles W. Wilkinson,
Laura D. Baker,
G. Stennis Watson,
Laura M. Bonner,
Maureen Callaghan,
James B. Leverenz,
Elaine C. Tsai,
Nadia Postupna,
Jing Zhang,
Johanna W. Lampe,
Suzanne Craft
Publication year - 2013
Publication title -
jama neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.298
H-Index - 231
eISSN - 2168-6157
pISSN - 2168-6149
DOI - 10.1001/jamaneurol.2013.396
Subject(s) - apolipoprotein e , medicine , endocrinology , glycemic index , cognitive decline , cerebrospinal fluid , apolipoprotein b , glycemic , dementia , disease , cholesterol , insulin
Sporadic Alzheimer disease (AD) is caused in part by decreased clearance of the β-amyloid (Aβ) peptide breakdown products. Lipid-depleted (LD) apolipoproteins are less effective at binding and clearing Aβ, and LD Aβ peptides are more toxic to neurons. However, not much is known about the lipid states of these proteins in human cerebrospinal fluid.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom